Indo US Bio-Tech Ltd

Indo US Bio-Tech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Indo US Bio-Tech Ltd

₹ 126 -6.99%
01 Dec - close price
indousagriseeds.com BSE: 541304 NSE: INDOUS
About

Incorporated in 2004, Indo US Bio-Tech Ltd is engaged in production and processing of commercial and vegetable seeds[1]

Key Points

Business Overview:[1]
IUBTL is involved in crop Research and Development through breeding, seed production, processing, packing, and marketing of hybrid and open pollinated varieties of agricultural crops

Website BSE NSE
  • Market Cap ₹ 251 Cr.
  • Current Price ₹ 126
  • High / Low ₹ 388 / 110
  • Stock P/E 49.7
  • Book Value ₹ 21.0
  • Dividend Yield 0.20 %
  • ROCE 15.4 %
  • ROE 16.9 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Debtor days have improved from 191 to 152 days.

Cons

  • Tax rate seems low
  • Company has high debtors of 152 days.
  • Promoter holding has decreased over last 3 years: -3.85%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Agricultural Food & other Products Other Agricultural Products

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022
39.76 39.39 49.39
35.78 34.04 42.60
Operating Profit 3.98 5.35 6.79
OPM % 10.01% 13.58% 13.75%
-0.01 0.03 0.18
Interest 0.88 1.18 1.20
Depreciation 0.23 0.27 0.46
Profit before tax 2.86 3.93 5.31
Tax % 11.54% -24.68% 4.71%
2.53 4.90 5.06
EPS in Rs 1.74 3.38 2.77
Dividend Payout % 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 25%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 3%
Stock Price CAGR
10 Years: %
5 Years: 49%
3 Years: 26%
1 Year: -51%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 17%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022
Equity Capital 6.07 6.07 9.17
Reserves 10.37 15.27 29.34
8.58 11.57 12.84
9.68 10.80 4.27
Total Liabilities 34.70 43.71 55.62
1.41 2.37 5.55
CWIP 1.28 1.99 2.32
Investments 0.00 0.00 0.00
32.01 39.35 47.75
Total Assets 34.70 43.71 55.62

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022
-0.84 0.16 2.70
-0.57 -1.78 -5.44
1.53 1.55 2.65
Net Cash Flow 0.12 -0.07 -0.09

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022
Debtor Days 192.60 228.97 151.87
Inventory Days 750.51
Days Payable 666.84
Cash Conversion Cycle 276.26 228.97 151.87
Working Capital Days 137.43 184.58 255.03
ROCE % 17.68% 15.45%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
70.17% 70.17% 70.17% 70.17% 70.17% 70.18% 70.18% 70.18% 70.18% 70.18% 70.18% 70.18%
29.83% 29.83% 29.83% 29.83% 29.83% 29.83% 29.82% 29.83% 29.82% 29.83% 29.83% 29.83%
No. of Shareholders 2592352513181,2271,1661,1339712,8282,7803,1124,130

Documents

Announcements

Annual reports

DRHP